臨床全般印象

WordNet

an outward appearance; "he made a good impression"; "I wanted to create an impression of success"; "she retained that bold effect in her reproductions of the original painting" (同)effect
(dentistry) an imprint of the teeth and gums in wax or plaster; "the dentist took an impression for use in preparing an inlay"
an impressionistic portrayal of a person; "he did a funny impression of a politician"
the act of pressing one thing on or into the surface of another; "he watched the impression of the seal on the hot wax"
a vague idea in which some confidence is placed; "his impression of her was favorable"; "what are your feelings about the crisis?"; "it strengthened my belief in his sincerity"; "I had a feeling that she was lying" (同)feeling, belief, notion, opinion
all the copies of a work printed at one time; "they ran off an initial printing of 2000 copies" (同)printing
involving the entire earth; not limited or provincial in scope; "global war"; "global monetary policy"; "neither national nor continental but planetary"; "a world crisis"; "of worldwide significance" (同)planetary, world, worldwide, world-wide
scientifically detached; unemotional; "he spoke in the clipped clinical monotones typical of police testimony"
relating to a clinic or conducted in or as if in a clinic and depending on direct observation of patients; "clinical observation"; "clinical case study"

PrepTutorEJDIC

〈C〉〈U〉(…に与える)『印象,感銘』《+『on』(『upon』)+『名』》 / 〈C〉〈U〉(人・物についての)『感じ』《+『of』+『名』》 / 〈U〉(漠然とした)感じ,考え / 〈C〉(圧力などでできた)(…の)跡,刻印,印(mark)《+『of』+『名』》 / 〈C〉(…の)まね《+『of』+『名』》 / 〈C〉印刷,刷り;(原版の)…刷
球の,球形の / 地球の,全世界の / 全体的な,総括的な
臨床の,臨床講義の / 病床の / 臨床的な,客観的な態度の

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/01/29 23:19:56」(JST)

wiki en

The Clinical Global Impression rating scales are commonly used measures of symptom severity, treatment response and the efficacy of treatments in treatment studies of patients with mental disorders (Guy, W., 1976). Many researchers, while recognizing the validity of the scale, consider it to be subjective as it requires the user of the scale to compare the subjects to typical patients in the clinician experience.

The Clinical Global Impression - Severity scale (CGI-S) is a 7-point scale that requires the clinician to rate the severity of the patient's illness at the time of assessment, relative to the clinician's past experience with patients who have the same diagnosis. Considering total clinical experience, a patient is assessed on severity of mental illness at the time of rating 1, normal, not at all ill; 2, borderline mentally ill; 3, mildly ill; 4, moderately ill; 5, markedly ill; 6, severely ill; or 7, extremely ill.

The Clinical Global Impression - Improvement scale (CGI-I) is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention. and rated as: 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse.

The Clinical Global Impression - Efficacy Index is a 4 point × 4 point rating scale that assesses the therapeutic effect of the treatment as 1, unchanged to worse; 2, minimal; 3, moderate; 4, marked by side effects rated as none, do not significantly interfere with patient's functioning, significantly interferes with patient's functioning and outweighs therapeutic effect.

References

Guy W: ECDEU Assessment Manual for Psychopharmacology —Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976, pp 218–222
Guy W: Clinical Global Impressions (CGI) Scale. Modified From: Rush J, et al.: Psychiatric Measures, APA, Washington DC, 2000.

This mental health-related article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人における複雑性悲嘆：治療 complicated grief in adults treatment
2. Treatment of systemic exertion intolerance disease (chronic fatigue syndrome)
3. 小児および思春期における自閉症スペクトラム障害：薬理学的介入 autism spectrum disorder in children and adolescents pharmacologic interventions
4. 病的賭博の概要 overview of gambling disorder
5. 脆弱X症候群：小児および思春期におけるマネージメント fragile x syndrome management in children and adolescents

English Journal

Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial.

Park HY, Lee BJ, Kim JH, Bae JN, Hahm BJ.SourceDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
Progress in neuro-psychopharmacology & biological psychiatry.Prog Neuropsychopharmacol Biol Psychiatry.2012 Mar 30;36(2):318-23. Epub 2011 Nov 28.
BACKGROUND: Among patients with cancer, the management of depression is very important to improve quality of life as well as distress. Because the efficacy of escitalopram, a potent serotonin reuptake inhibitor, has not been well evaluated in cancer patients, we investigated its effects on depressio
PMID 22142651

Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.

Ciudad A, San L, Bernardo M, Olivares JM, Polavieja P, Valladares A, Gilaberte I.SourceDepartment of Clinical Research and Development, Lilly, S.A. Avenida de la Industria, 30, 28108 Alcobendas, Spain. ciudad_antonio@lilly.com
Progress in neuro-psychopharmacology & biological psychiatry.Prog Neuropsychopharmacol Biol Psychiatry.2012 Mar 30;36(2):245-50. Epub 2011 Oct 26.
OBJECTIVES: To evaluate the incidence rate of relapse, the clinical profiles, and the therapeutic interventions employed for patients with schizophrenia deemed as likely nonadherers to oral antipsychotic drugs.METHODS: A cohort of 597 outpatients whose therapy was modified because of a psychiatrist-
PMID 22056291

Long-term efficacy and safety of gabapentin enacarbil in Japanese restless legs syndrome patients.

Inoue Y, Uchimura N, Kuroda K, Hirata K, Hattori N.SourceJapan Somnology Center, Neuropsychiatric Research Institute, 1-24-10 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan. inoue@somnology.com
Progress in neuro-psychopharmacology & biological psychiatry.Prog Neuropsychopharmacol Biol Psychiatry.2012 Mar 30;36(2):251-7. Epub 2011 Oct 19.
Several short- and long-term studies conducted in Europe/North America have demonstrated good efficacy and tolerability of 600-1800 mg gabapentin enacarbil (GEn). However, no studies have evaluated the efficacy of long-term treatment with GEn in Asian patients. Therefore, the objective of this study
PMID 22036917